SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-016722
Filing Date
2020-08-26
Accepted
2020-08-26 08:30:16
Documents
24
Period of Report
2020-08-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39576
5 ex99-1.htm EX-99.1 18797
6 ex99-1_001.jpg GRAPHIC 6927
7 ex99-2.htm EX-99.2 7255
8 ex99-2_001.jpg GRAPHIC 53965
9 ex99-2_002.jpg GRAPHIC 148760
10 ex99-2_003.jpg GRAPHIC 83220
11 ex99-2_004.jpg GRAPHIC 93960
12 ex99-2_005.jpg GRAPHIC 79094
13 ex99-2_006.jpg GRAPHIC 59926
14 ex99-2_007.jpg GRAPHIC 76787
15 ex99-2_008.jpg GRAPHIC 76671
16 ex99-2_009.jpg GRAPHIC 40922
  Complete submission text file 0001493152-20-016722.txt   1240561

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vbiv-20200826.xsd EX-101.SCH 3195
3 XBRL LABEL FILE vbiv-20200826_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE vbiv-20200826_pre.xml EX-101.PRE 22716
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 201134154
SIC: 2834 Pharmaceutical Preparations